Lung Cancer

Lung cancer is the world's most common cancer and kills more people than any other cancer. In 2008, approximately 1.52 million new cases of lung cancer were diagnosed worldwide, with 1.31 million people dying from the disease.(14) In the United States, an estimated 161,840 deaths, accounting for 29 percent of all cancer deaths, occurred in 2008, according to the American Cancer Society (ACS).

Lung Cancer

Lung cancer is a common and very serious form of cancer, with more than 40,000 people diagnosed with the condition each year in the UK. The symptoms of lung cancer do not present in the early stages, but when symptoms do eventually present, they usually include the following:

Lung Cancer and Electrolyte Imbalances

Lung Cancer Screening Procedure

Palliative and End-of-Life Care in Lung Cancer

Lung Cancer Diagnosis

Types of Lung Cancer Surgery

Lung Cancer Symptoms

Carcinogens in Cigarette Smoke

Pulmonary Resection in Lung Cancer

Lung Cancer Treatments

Lung Cancer Causes

Everything You Need to Know About Giving Up Cigarettes

See more featured articles »

Secondary Lung Cancer

How to Prevent Lung Cancer

Lung Plethysmography Procedure

What are the Survival Rates for Lung Cancer?

Lung Cancer Research

Lung Cancer Genetics

Lung Cancer Questions

Lung Cancer in Women: Understanding the Increasing Risk

Lung Cancer Pathogenesis

Lung Cancer: Radiotherapy and Chemotherapy

Lung Cancer Risk Factors

Epidemiology of Lung Cancer

Exploring Diversity in Lung Cancer: Impact on Incidence, Prognosis, and Treatment Strategies

What Causes Lung Cancer in Non-Smokers?

Pulmonary Transplant (Lung Transplant)

Immunotherapy: The Future of Lung Cancer Treatment?

Lymph Nodes in Lung Cancer

Latest Lung Cancer News and Research

Global analysis reveals up to four in ten cancer cases could be prevented

Up to four in ten cancer cases worldwide could be prevented, according to a new global analysis from the World Health Organization (WHO) and its International Agency for Research on Cancer (IARC).

4 Feb 2026

Most commercially insured patients live with chronic conditions

The majority (57.5 percent) of commercially insured patients had at least one chronic condition in 2024. The average allowed amount for a patient with no chronic conditions was $1,590, while the average allowed amount for a patient with one chronic condition was nearly double ($3,039).

2 Feb 2026

Integrated Monte Carlo and deep learning improve radiotherapy QA

Led by Professor Fu Jin, the study addresses a critical challenge in radiation therapy: balancing the computational speed and accuracy of EPID-based dose verification.

31 Jan 2026

Additional lymph node evaluation needed during surgery to accurately identify lung cancer spread

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation is needed during surgery for non-small cell lung cancer (NSCLC) to accurately identify cancer spread.

31 Jan 2026

Time of radiotherapy can influence the effectiveness of cancer treatment

A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Seville, in collaboration with the Virgen Macarena University Hospital, have identified a fundamental mechanism that links the 24-hour circadian cycle to the precise repair of DNA breaks.

30 Jan 2026

Study offers a practical strategy to enhance effectiveness of immune checkpoint inhibitors

Cancer immunotherapy has transformed modern oncology by harnessing body's own immune system to combat malignant disease.

29 Jan 2026

Poop pills could help cancer patients respond to immunotherapy while reducing toxic side effects

Fecal microbiota transplants (FMT), can dramatically improve cancer treatment, suggest two groundbreaking studies published in the prestigious Nature Medicine journal.

28 Jan 2026

Orphan noncoding RNAs define cancer identity and enable blood-based monitoring

We knew we had something interesting with T3p, a single small RNA found in breast cancer but absent from normal tissue.

24 Jan 2026

Trojan horse immunotherapy opens tumors to immune system attack

Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells directly, it targets the cells that protect them.

22 Jan 2026

Cancer vaccines enter a new era of personalized immunotherapy

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, and effective immunotherapies, particularly when combined with other cancer treatments.

22 Jan 2026

AI tool predicts metastatic risk in multiple cancers

Why do some tumors spread while others remain localized? The mechanisms governing the metastatic potential of tumor cells remain largely unknown — yet understanding this is crucial for optimizing patient care.

22 Jan 2026

Understanding tumor growth patterns helps guide treatment after lung cancer

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer grows.

21 Jan 2026

Newly discovered survival pathway explains stubborn EGFR-driven lung cancers

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene called EGFR (epidermal growth factor receptor).

21 Jan 2026

Lung cancer deaths leveling off for EU women, except in Spain

After increasing for more than 25 years, lung cancer death rates are finally levelling off among women in European Union (EU) countries apart from Spain, according to predictions of mortality rates from the disease for 2026.

19 Jan 2026

Expanded school tobacco prevention in California is linked to lower youth vaping and smoking

A statewide evaluation found that California schools receiving TUPE funding delivered more antitobacco education and activities and reported lower student tobacco use than non-funded schools. The association was driven mainly by reduced vaping, within a broader environment of strong statewide tobacco control.

18 Jan 2026

Cancer mortality drops 34% as treatments and early detection improve

The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and mortality across different populations.

16 Jan 2026

Bacterial metabolite enhances immune checkpoint therapy against lung cancer

UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer immunotherapy treatment in mice and can now be made into a drug for testing in humans.

14 Jan 2026

DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly approved immunotherapy called tarlatamab.

14 Jan 2026

Novel drug combination overcomes resistance in aggressive KRAS-mutated lung cancer

A research team at the Medical University of Vienna has discovered a new approach to treating a particularly frequent and difficult-to-treat form of lung cancer.

13 Jan 2026

Durvalumab extends survival in small cell lung cancer but raises cost concerns

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC).

9 Jan 2026